Condition
Liposome Bupivacaine
Total Trials
3
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Not Yet Recruiting2
Recruiting1
Clinical Trials (3)
Showing 3 of 3 trials
NCT07667439Not ApplicableNot Yet RecruitingPrimary
The Effect of Liposomal Bupivacaine Erector Spinae Plane Block
NCT07442539Not ApplicableRecruiting
The Efficacy and Safety of Liposomal Bupivacaine in Relieving Postoperative Pain After Hemorrhoid Surgery
NCT06701539Not ApplicableNot Yet RecruitingPrimary
Liposomal Bupivacaine for Postoperative Pain After Craniotomy
Showing all 3 trials